trending Market Intelligence /marketintelligence/en/news-insights/trending/Ghm6liG0NW_iTmHtmMow1Q2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Generex adds Emmaus CEO to board

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Blog

COVID-19 Impact & Recovery: Private Equity

COVID-19 Impact & Recovery: Corporates


Generex adds Emmaus CEO to board

Generex Biotechnology Corp. added Emmaus Life Sciences Inc. Chairman and CEO Yutaka Niihara to its board of directors as executive chairman.

Generex Biotechnology previously signed a letter of intent to acquire a 51% interest in Emmaus.